24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
66.67% |
|
IL 2 FORCE FIELD BENCHMARKING |
33.33% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
36.21% |
|
ANTIBODY DYNAMICS SIMULATION |
31.9% |
|
IL 2 FORCE FIELD BENCHMARKING |
11.21% |
|
PARKINSONS |
10.34% |
|
IL 2 DYNAMICS SIMULATIONS |
10.34% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
21.94% |
|
ANTIBODY DYNAMICS SIMULATION |
19.54% |
|
ANTIBODY DYNAMICS |
14.2% |
|
IL 2 FORCE FIELD BENCHMARKING |
10.12% |
|
ANTIBODY AFFINITY MATURATION |
9.62% |
|
IL 2 DYNAMICS SIMULATIONS |
8.3% |
|
IL 2 RECEPTOR DYNAMICS |
6.42% |
|
ALZHEIMERS |
4.08% |
|
STP6 SUGAR TRANSPORT |
1.76% |
|
PARKINSONS |
1.09% |
|
ATSTP10 SUCROSE TRANSPORT |
.91% |
|
SUCROSE TRANSPORT PLANTS |
.7% |
|
UNSPECIFIED |
.56% |
|
MEMBRANE TRANSPORT |
.35% |
|
PLANT SUCROSE TRANSPORT |
.29% |
|
CANCER |
.12% |